by Jay Nanduri | Oct 28, 2024 | Technology
In the journey toward advancing healthcare research, trust in AI tools is essential. Truveta is committed to not only delivering powerful AI-driven data insights but also ensuring transparency, quality, and speed for researchers. A significant part of this commitment...
by Truveta staff | Sep 26, 2024 | Technology
Despite advances in guideline-directed medical therapy, heart failure (HF) readmission rates have worsened over the past decade. Optimizing acute inpatient decongestion is critical in mitigating HF morbidity and mortality, but few new treatment strategies have emerged...
by Truveta staff | Aug 30, 2024 | Technology
Continuing with my series on AI, today I want to discuss the following question: How to make healthcare data available for clinical and life science research while leveraging AI in a safe and compliant manner? There are four aspects to compliance in healthcare...
by Truveta staff | Jul 30, 2024 | Technology
In this blog I will discuss our approach to scaling our AI technologies across multiple dimensions while controlling development costs, operational costs, and assuring stability. LLMs are a powerful new technology, but they also have large development, operational,...
by Truveta staff | Jul 1, 2024 | Technology
In this post, I would like to discuss the way we addressed the following challenge: How to ensure that the AI technologies used in our platform have requisite accuracy and explainability while assuring fairness and avoidance of bias Healthcare and life science...
by Truveta staff | Jun 17, 2024 | Data, News, Technology
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
